Literature DB >> 25765212

Words of wisdom. Re: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Timothy J Daskivich1, Arie Belldegrun2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25765212     DOI： 10.1016/j.eururo.2014.12.052

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  14 in total

1.  [Construction and evaluation of dual-effect cord blood natural killer cells expressing highaffinity PD-1 and chimeric antigen CD19 receptor].

Authors:  H Zhong; Q Zou; H Liu; X Wang; S DU; H Liang; Z Wu; J Ye; Q Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-12-20

2.  Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Authors:  Daniel Kerage; Megan S F Soon; Brianna L Doff; Takumi Kobayashi; Michael D Nissen; Pui Yeng Lam; Graham R Leggatt; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

Review 3.  Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Authors:  Mengling Wu; Qianrui Huang; Yao Xie; Xuyi Wu; Hongbo Ma; Yiwen Zhang; Yong Xia
Journal:  J Hematol Oncol       Date:  2022-03-12       Impact factor: 17.388

4.  Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.

Authors:  Kaiyan Chen; Ziyu Zhu; Nan Zhang; Guoping Cheng; Fanrong Zhang; Jiaoyue Jin; Junzhou Wu; Lisha Ying; Weimin Mao; Dan Su
Journal:  Med Sci Monit       Date:  2017-09-26

5.  Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy.

Authors:  Mayassa J Bou-Dargham; Linlin Sha; Qing-Xiang Amy Sang; Jinfeng Zhang
Journal:  BMC Cancer       Date:  2020-06-18       Impact factor: 4.430

Review 6.  [Progress on PD-1/PD-L1 Checkpoint Inhibitors in Lung Cancer].

Authors:  Di Zhang; Jiaqi Huang; Chufeng Zhang; Yan Guan; Qisen Guo
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-06-20

7.  Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells.

Authors:  Xiufeng Jiang; Hui Wu; Wei Zhao; Xiao Ding; Qian You; Feng Zhu; Meifang Qian; Ping Yu
Journal:  Cancer Cell Int       Date:  2019-03-21       Impact factor: 5.722

Review 8.  Long non-coding RNAs associated with non-small cell lung cancer.

Authors:  Yuting Zhan; Hongjing Zang; Juan Feng; Junmi Lu; Lingjiao Chen; Songqing Fan
Journal:  Oncotarget       Date:  2017-08-09

9.  MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.

Authors:  Fen Huang; Bo Wang; Jiangzheng Zeng; Shenggang Sang; Junhua Lei; Yanda Lu
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

10.  Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment.

Authors:  Maike Trommer-Nestler; Simone Marnitz; Martin Kocher; Daniel Rueß; Max Schlaak; Sebastian Theurich; Michael von Bergwelt-Baildon; Janis Morgenthaler; Karolina Jablonska; Eren Celik; Maximilian I Ruge; Christian Baues
Journal:  Int J Mol Sci       Date:  2018-09-07       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.